Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines
Clinical trial NCT00735020 · COMPLETED
Trial details
- NCT number
- NCT00735020
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2008-08-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.